An Enquiry (R. Rowe) to be heard by the Disciplinary Panel on Monday 26 October 2020

Published 2020/10/23

i. The independent Disciplinary Panel of the British Horseracing Authority (BHA) will convene on Monday 26 October 2020 to consider whether or not Richard Rowe, a licensed trainer and the Responsible Person, is in breach of Rule (G)2.1 of the pre 1 September 2019 Rules of Racing due to the presence of phenylbutazone and oxyphenbutazone in a post-race sample taken from LIKE SULLY (IRE) following The Matchbook Betting Podcast Handicap Chase at Kempton on 14 May 2018; and

ii. Whether LIKE SULLY (IRE) should be disqualified from the relevant race under Rule (A)74.2 ground 3.

Notes to Editors:

1. The Panel for the Enquiry will be: HH Brian Barker CBE QC (Chair), Austin Allison and Steve Winfield. Two days have been set aside for this hearing.

2. Phenylbutazone is a non-steroidal anti-inflammatory. It is licensed for oral administration to horses in the UK, and a detection time of 168 hours (7 days) has been published by the BHA. Phenylbutazone is a Prohibited Substance on Raceday as defined in Schedule 1 of Manual G of the pre 1 September 2019 Rules of Racing, meaning that it is permitted for use in training but it must not be present in a horse's system on raceday. Oxyphenbutazone is a metabolite of phenylbutazone and also a prohibited substance.

3. Due to the current situation and resulting difficulties arising from the corona virus, temporary changes have been made to how the Judicial Panel operates. Initial changes can be seen in a statement here issued on 1 April, with a further operational update issued on 1 June here.

4. As referenced in the above, media wishing to attend remote hearings must read and agree in writing to the media protocol referenced in the update issued on 1 June, which is also available here.

To express interest in attending a remote hearing, please contact Joe Rendall via [email protected].

Please note, the BHA Judicial Panel is an independent body which encompasses the Disciplinary Panel, Appeal Board and Licensing Committee.

It receives administrative support from the BHA via the Judicial Panel Secretary.